In the Hatch-Waxman arena of patent litigation, the crisscross of patent laws and FDA regulations is always in play. In the recent Federal Circuit decision in Jazz Pharmaceuticals, Inc. v. Avadel CNS ...
Before Moore, Schall, and Taranto. Appeal from the Patent Trial and Appeal Board. Summary: The Board erred by finding method-claim steps connected by “and” to be conditional and by never explaining ...
“The insurance claim may comprise any of a claim against one or more of a health insurance, a worker compensation insurance, a liability insurance, a homeowner’s insurance, a property casualty ...
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...
During the rapid development of the biotech industry in the nineties, large numbers of tests, research tools and assays were developed. Such inventions were primarily patent-protected using "method" ...
The Recentive decision exemplifies the Federal Circuit’s skepticism toward claims that dress up longstanding business problems in machine-learning garb, while the USPTO’s examples confirm that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results